The American College of Rheumatology has updated its COVID-19 vaccine clinical guidance for patients with rheumatic diseases to recommend a fourth mRNA vaccine dose in patients receiving immunosuppressive or immunomodulatory therapy.“It remains important for rheumatology providers to assess the vaccination status of all patients with rheumatic diseases,” Jeffrey Curtis, MD, MPH, chair